Blog - Page 1331 of 5712

MondayJun 21, 2021 11:26 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Revolutionizing Portable EEG Diagnostics Space

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, has created powerful yet affordable solutions that bring brain diagnostics to settings where it was previously impossible or difficult to conduct neurological testing. Concussions resulting from head trauma in contact sports are usually minor; however, some can lead to significant long-term cognitive, physical and psychosocial impairments. “Unfortunately,” observes a recent article, “at this moment, it is challenging to differentiate between the two.” CT is the most commonly used imaging procedure but is not effective when conducting a post-concussion examination. MRIs and neuropsychologic testing are somewhat more effective but are…

MondayJun 21, 2021 11:13 am

QualityStocksNewsBreaks – Psychedelic Capital: June 2021 to Feature Top Companies, Newest Opportunities, Deep Industry Insights

Microdose Psychedelic Insights, a cutting-edge media company focused on providing content, analysis and engaging events designed to drive the psychedelics industry to the forefront of modern medicine, will be hosting the upcoming Psychedelic Capital: June 2021. The conference is slated to take place in an entirely virtual format on June 30, 2021. The event will feature some of the top companies, latest IPOs, newest opportunities, and deepest industry insights within the sector. The Psychedelic Capital conference is part of an investor conference series diving deep into psychedelic medicine investment. An introductory talk delivered by Richard Skaife, Patrick Moher and Henri…

MondayJun 21, 2021 11:13 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Focused on Building Leading U.S. Ecosystem

Recent agreements have been strategic steps taken by BEV to position itself in growing U.S. market Agreements involve key manufacturing, distribution, fulfillment partners TRACE products feature the company’s alkaline, plant-based mineral beverages and nutraceuticals Committed to creating a powerful ecosystem focused on developing and manufacturing alkaline, plant-based, and cannabinoid beverages and supplements, BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has announced a number of agreements recently. Each agreement has been part of a strategic business plan as the company moves into the United States and strengthens its position as a leading resource of high-quality health and wellness beverages and…

MondayJun 21, 2021 10:57 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Host Inaugural Sequire Blockchain Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced plans to host the first-ever Sequire Blockchain Conference; the virtual event will be held on July 15, 2021, beginning at 11:30 a.m. ET. SRAX announced that the agenda for the groundbreaking event will feature more than a dozen leading blockchain and crypto companies; in addition, industry experts are slated to address participants, providing invaluable insight into the industry. The announcement noted that this inaugural conference is the perfect venue to unlock new investment opportunities in the blockchain…

MondayJun 21, 2021 10:45 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Appoints Current VP, Controller as Interim CFO

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness company offering premium probiotic supplements and products containing CBD, announced the appointment of an interim chief financial officer; the company named Maria Leal, who is currently serving as both controller and company vice president, to the position. A CPA and MBA, Leal has built a strong reputation for strong financial management over the past two decades. She has served in a variety of financial accounting roles and landed at HempFusion in 2019. Management noted that Leal has been instrumental in all financial reporting aspects for the company…

MondayJun 21, 2021 10:24 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Participate at the Emerging Growth Conference

Cybin (NEO: CYBN) (OTCQB: CLXPF) has announced that its CEO Doug Drysdale will be participating at the 2021 Emerging Growth Conference, which is scheduled for June 23, 2021.As part of his participation, Drysdale will be presenting a live webcast featuring Cybin, a biotechnology company focused on progressing psychedelic therapeutics. Drysdale’s presentation is scheduled to begin at 2 p.m. ET. Interested individuals can register to view the Cybin executive’s presentation via the webcast. Following the conference, an archived version of the presentation will be available at www.EmergingGrowth.com. To view the presentation, visit https://ibn.fm/i4DMQ To view the full press release, visit https://ibn.fm/Q64Zb…

FridayJun 18, 2021 2:46 pm

6th Annual Medical Device Human Factors & Usability Conference To Offer Unique Strategies and Effective Design Roadmaps

June 22-24, 2021Virtual Event The 6th Annual Medical Device Human Factors & Usability Conference will be held from June 22-24, 2021, at the Q1 Productions dynamic virtual platform. Companies, representatives, and professionals from the Medical Device, Diagnostic and Combination products industry are invited to attend this virtual event. Operating since 2006, Q1 Productions specializes in delivering educational programming through its curated conferences and research-based events. The programs conducted in Q1 Production conferences are focused and learning is achieved through fun and interactive sessions. The sponsors of the event are: BlackHägen Design is a multidisciplinary, user-research, and product development firm. UserWise…

FridayJun 18, 2021 2:43 pm

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) CEO to Discuss Disruptive Products Harnessing Cutting-Edge Science and Tech in ‘New to the Street’ Interview

Grapefruit USA (OTCQB: GPFT), a California-based hemp and cannabis company, will be featured in FMW Media’s “New to the Street” / Newsmax TV’s Sunday, June 20, 2021, broadcasting lineup of its national syndicated one-hour show airing at 10-11 a.m. ET. Grapefruit USA’s CEO Bradley Yourist will be among the eight interviews with business representatives from various innovative companies. Yourist will discuss Grapefruit USA’s permits, patents, licenses, manufacturing, laboratory, and distribution of cannabis products, as well as its Hourglass(TM) brand. Grapefruit delivers hemp-derived and cannabis products that have fundamentally changed the way individuals use THC and CBDs, capitalizing on rising demand…

FridayJun 18, 2021 2:35 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Making Advances in Bladder Cancer Treatment Through Proprietary Imaging Technology

Company’s i/Blue Imaging System(TM) is expected to be completed in 2022 The American Cancer Society estimates that 2021 will see 83,370 new cases of bladder cancer and approximately 17,200 deaths More than half of the patients who underwent a cystoscopy to remove non-muscle-invasive bladder cancer will experience recurrence The bladder cancer market was valued at $3.43 billion in 2020, and is anticipated to reach $4.71 billion by 2028 According to the American Cancer Society, new cases of bladder cancer in the United States are expected to reach 83,730 in 2021 and deaths are anticipated to reach 17,200 (https://ibn.fm/zNRWl). Approximately 50%…

FridayJun 18, 2021 2:22 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reports First Quarter Financials; Anticipates Improved Patient Outcomes with Berubicin

Company expects reporting on interim analysis for the first 18 patients of a Phase 2 multicenter clinical trial of Berubicin in adult GBM patients during the first half of 2022 One patient from the first Berubicin trial has survived cancer-free for 14 years, while two patients saw tumor reduction of up to 80 percent CNS Pharmaceuticals reported a net loss of $3.6 million, attributed to increased personnel, activity preparing for clinical trials, drug manufacturing, and labor for the Phase 2 study The global brain tumor therapeutics market is expected to grow at a CAGR during 2020-2025, resulting in forecasted market…

Site Search

Company Search